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Abstract We report on the design of superparamagnetic
nanoparticles capable of selectively isolating targeted bacteria
(Legionella pneumophila, serogroup 1) from aqueous solu-
tions. The surface of magnetite nanoparticles (NP) was func-
tionalized with a heterobifunctional poly(ethylene glycol) li-
gand containing reactive groups for covalent coupling of poly-
clonal antibodies against L. pneumophila. These bioconju-
gates were used to label and magnetically isolate L.
pneumophila. Flow cytometry revealed high separation and
efficiency in this regard. The strain specificity and efficiency
of the magnetic NP was tested with recombinant strains of E.
coli (expressing the red fluorescent protein) and L.
pneumophila (expressing the green fluorescent protein). The
detection limit of the method (by flow cytometry) is 104
cells mL-1. The results indicate that the new multifunctional
NPs are capable of selectively attracting pathogens from a
complex mixture and with high efficiency. This, conceivably,
paves the way to pre-concentration protocols for numerous
other pathogens.
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Introduction
Iron oxide nanoparticles (NP) have become popular since they
were applied in fields like magnetic resonance imaging
(MRI), hyperthermia or drug delivery carriers.[1–5] For most
applications, magnetite (Fe3O4) is the preferred species of
iron oxide, because of its interesting magnetic properties.[6]
If the NP size ranges between 5 and 25 nm, they exhibit
superparamagnetic behavior. This is highly valuable because
it combines the large magnetic moment of a ferromagnetic
material, with the convenient handling of a paramagnet, which
has no net moment without an external magnetic field.[7]
Consequently these NP are excellent materials for performing
magnetic separation of target ions, molecules or cells
from solution.[8, 9] However two more properties of
the material are crucial for these applications: their col-
loidal stability in the medium and their selectivity to-
wards the target. To achieve the first requirement, multiple
solutions have been reported. Typically the surface of the NP
is coated with a polymer, silica or organic ligands, to introduce
functionalities and improve its colloidal properties.[10–12]
Recently we reported a strategy to efficiently functionalize
the surface of iron oxide nanoparticles with a
heterobifunctional poly(ethylene glycol) (PEG) ligand and
couple antibodies (Ab) to this layer.[13]
Depending on the target; organic ligands, Ab or
nanobodies with a high affinity can be introduced to acquire
selective targeting [9, 14–18]. Xu et al. reported that these NP-
Ab bioconjugates can help in the separation of cancer cells
from blood.[9] However, to our knowledge, no references are
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present in literature of studies describing a full cell separation
study with multiple cell detection techniques. In this manu-
script we focus on the magnetic separation of Legionella
pneumophila serogroup 1 bacteria from aqueous solutions.
These gram-negative bacteria are a wide-spread problem in
cooling towers, air-conditioning systems, fountains and
showers [19]. They are known to cause the Legionnaires’
disease or legionellosis, a serious form of pneumonia [20].
Their detection is mandatory in all publicly accessible wa-
ter system, like swimming pools, but also in cooling circuits
and wastewater. Different methods, such as filtration, centri-
fugation or immunomagnetic isolation by microparticles, are
currently available to separate these bacteria from their aque-
ous environment for subsequent quantification [21–23]. How-
ever all these methods have some specific drawbacks. Filtra-
tion has a profound influence on cell viability and centrifuga-
tion is less appropriate for large volumes. Moreover these
methods are not target specific; so all organisms are retained,
including possible inhibitors that might complicate further
quantification. Immunomagnetic isolation by microparticles
is target specific, but the efficiency is low and cell damage
might occur due to the localized excessive magnetic forces
[24]. After isolation, quantification of the bacteria can be per-
formed by traditional plate counting or quantitative real-time
polymerase chain reactions (qPCR). Even though the cultur-
ing method is still considered as the standard, it is very time-
consuming and inconvenient. qPCR is substantially faster but
is very susceptible to inhibitors, such as metal salt, surfactants
or polysaccharides [25].
In comparison to microparticles, the proposed nanoparti-
cles have a more than 100 times larger surface to volume ratio,
which allows binding more Ab to the nanoparticle’s surface.
Moreover more particles can interact with the cells, resulting
in a larger net magnetic moment, hence lowering separation
time. On top of that, the magnetic forces are more evenly
spread across the cell’s surface, which will increase the
amount of intact organisms that can be collected.
In this manuscript we report the design of a functionalized
iron oxide (Fe3O4) nanoparticle with customized PEG ligands
and antibodies. These particles were tested extensively on
their ability to specifically attract and separate Legionella
pneumophila serogroup 1 bacteria from an aqueous solution.
To underline the efficiency, the targeted bacteria were also
separated from a mixture of L. pneumophila and Escherichia
coli bacteria.
Negative control experiments reported in literature often
make use of nanoparticles without a targeting ligand (f.i. an
antibody). The recent scientific discussions about protein co-
ronas have shown that the interaction between the nanoparti-
cle’s surface and another entity is largely dependent on its
coating.[26] Therefor we opted for a negative control com-
posed of iron oxide nanoparticles, conjugated with a non-
Legionella targeting antibody (targeting murine PAI-1).
Experimental
Materials
Allyl-PEG10-OH was obtained from Polysciences, Inc (www.
polysciences.com). 2,2-dimethoxy-2-phenylacetophenone
(DMPAP, 99 %), 4-dimethylaminopyridine (DMAP, 99 %), 1-
Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), succinic
anhydride (99 %) and mercaptopropyltrimethoxysilane (95 %)
were purchased from Sigma Aldrich (www.sigmaaldrich.com).
N-hydroxy succinimide (98+%)was purchased fromAlfaAesar
(www.alpha.com). Triethylamine was obtained from Janssen
Chimica (www.acros.com). 2-(N-morpholino) ethanesulfonic
acid monohydrate (MES) was purchased at Fluka (www.
sigmaaldrich.com/Fluka). All ultrasonication steps were
performed in a Branson 5510 sonicator bath.
Antibody purification
“New Zealand White” rabbits were immunized with
Legionella pneumophila serogroup 1 and murine PAI-1.[27]
After collecting the serum, the full IgG fraction was purified
using protein A ProSep beads.[28] These polyclonal fractions
were used without additional enrichment towards the target
protein and denoted as Ab that target L. pneumophila (pAb
Leg) and Ab that target murine PAI-1 ( pAb mur PAI-1; neg-
ative control).
Synthesis of the ligands, nanoparticles and functionalization
procedure
The heterobifunctional PEG ligand was synthesized as de-
scribed in our previous report.[13] Allyl-PEG10-OH (1, 1 eq,
4,00 mmol, 1.992 g) was mixed with succinic anhydride
(1.1 eq, 4.40 mmol, 440 mg) and 4-dimethylaminopyridine
(DMAP) (0.02 eq, 0.08 mmol, 9.7 mg). This mixture was
stirred and heated to 50 °C for 16 hours. The product (2)
was purified twice by precipitation in cold diethyl ether, cen-
trifugation and drying in vacuum. 1H NMR (300 MHz,
CDCl3): δ (ppm) 2.65 (s, 4H), 3.55–3.75 (m, 38H), 4.02 (d,
2H), 4.26 (t, 2H), 5.15–5.32 (m, 2H), 5.85–5.95 (m, 1H). 13C
NMR (75 MHz, CDCl3): δ (ppm) 29.2, 29.5, 63.8, 68.9, 69.3,
70.5, 72.2, 117.1, 134.7, 172.1. MS (chemical ionization):
m/z=499, 101.
To introduce the siloxane onto the heterobifunctional PEG
molecule, allyl-terminated PEG (1 mmol in total, mixture of
modified (0.1 mmol) and unmodified (0.9 mmol)) was mixed
with (3-mercaptopropyl) trimethoxysilane (1 eq, 1 mmol,
185.7 μL) and 2,2-dimethoxy-2-phenylacetophenone
(DMPAP, 0.05 eq, 0.05 mmol, 12.8 mg). This mixture was
stirred during 1 hour in a UV reactor, equipped with 3 LEDs
(365 nm, output power 200 mW). The product (3) was used
without further purification. 1H NMR (300 MHz, CDCl3): δ
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(ppm) 0.76 (t, 2H), 1.70 (m, 2H), 1.85(m, 2H), 2.55 (m, 4H),
2.64 (s, 4H), 3.57 (s, 9H), 3.55–3.75 (m, 40H), 4.26 (t, 2H).
The synthesis of magnetite NP and coating their surface
with siloxanes was performed as described in our previous
manuscript.[13, 29] In general, 1 mmol of siloxanes was
mixed with 100 mg of Fe3O4 NP in 50 mL of toluene. To this
mixture triethylamine (2.5 mL) and 50 μL of water were
added. The solution was placed in an ultrasonication
bath for 5 hours, after which 50 mL of heptane was
added to precipitate the particles (dispersion becomes
turbid). Afterwards, they were attracted magnetically
and washed 3 times with acetone. Finally the particles were
dried in vacuum and dispersed in MilliQ water (with a con-
centration up to 20 mg mL-1).
Antibody coupling
The concentrated nanoparticle solution was diluted in 50 mM
2-(N-morpholino)ethanesulfonic acid (MES) buffer, pH 5.5,
to reach a final concentration of 3 mg mL−1. 0.75 mg 1-Ethyl-
3-(3-dimethylaminopropyl)carbodiimide (EDC) and
0.75 mg N-hydroxysuccinimide (NHS) was added to 1 mL
of this solution and shaken for 20 min to activate the carbox-
ylic acids. The antibodies (75 μg) were diluted in 2 mL of the
same MES buffer after which both solutions were mixed and
shaken for 1 hour. To separate the particles from the solution, a
Miltenyi Biotech MS magnetic column was used. After rins-
ing the column with MilliQ water, the nanoparticle dispersion
was loaded onto the column, which was placed inside a circu-
lar NdFeB magnet. The column was washed 2 times with
1 mL of sodium phosphate buffer (20 mM, pH 7). To elute
the particles, the column was removed from the magnet and
0.5 mL of phosphate buffer and subsequently 0.5 mL of
MilliQ were used as eluents.
Bacterial strains and growth conditions
Recombinant strains of E. coli and L. pneumophila serogroup
1 expressing the Red Fluorescent Protein (rfp) Green Fluores-
cent Protein (gfp) genes respectively were used to test strain
specificity and efficacy of the iron oxide nanoparticles. The
transformed bacteria were cultivated in the presence of appro-
priate antibiotics (10 μg of kanamycin mL-1 for rfp and
5 μg mL−1 chloramphenicol for gfp) to ensure plasmid main-
tenance. Briefly, Legionella bacteria were cultured by stan-
dard procedures at a temperature of 37 °C on buffered yeast
extract agar containing α-ketoglutarate (BCYE-α) supple-
mented with L-cysteine and ferric pyrophosphate. [30] E. coli
bacteria (LMG2092T, rfp labelled and kindly given by Prof.
N. Boon, UGent, Belgium) were grown in Luria broth (LB)
medium supplemented with kanamycin (10 mg mL−1) and
incubated overnight at 30 °C.
Magnetic separation of bacteria
Separate L. pneumophila and E. coli solutions were prepared
by spiking Ringer’s Solution (Oxoid) with scraped bacteria
from the culture plates following the preparation of 10-fold
dilution series. In general, 4 different concentrations of
Legionella bacteria (1E7, 1E6, 1E5 and 1E4 cells mL−1) were
tested in either monospecies suspensions or mixed suspen-
sions with added E. coli bacteria. In general, 300 μL of each
bacteria solution was mixed with 250 μL of NP solution
(0.5 mg NP). Then, this mixture was placed on a rotator at
room temperature for 1 hour and afterwards separated by a
magnetic column. The supernatant was collected and the col-
umn was washed with 1 mL of MilliQ water. To elute the NP
and bacteria, the column was removed from the magnet and
1 mL of MilliQ was used as an eluent (see Fig. 3b-c).
Flow cytometry
Cell numbers of L. pneumophila and E. coli were determined
by flow cytometry using an Attune® Acoustic Focusing
Cytometer (Life Technologies, Gent, Belgium) equipped with
a 488 nm laser, a forward scatter (FSC) diode detector, and a
photomultiplier tube (PMT) SSC detector. The instrument was
checked for stable fluidic alignment using Performance track-
ing beads (Life Technologies). Bacterial fractions expressing
gfp and rfp fluorescence were detected using, respectively, the
BL-1 (530/30 nm) and BL-3 (640 LP) detector. The different
fractions of the separation experiment were fixed with 4 %
PFA and were diluted 100-fold. The collection rate of the
instrument was 25 μL min−1 and a total of 50 μL was ana-
lyzed per sample
Quantitative PCR
For the specific detection of L. pneumophila, a TaqMan qPCR
designed by P. Declerck & J. Behets was used.[31] DNAwas
extracted using the QIAGEN DNeasy Blood & Tissue Kit.
The primers were based on the macrophage infectivity poten-
tiator (mip) gene and were: LPQF (5′–TTCATTTGYT
GYTCGGTTAAAGC) and LPQR (5′–AWTGGCTAAAGG
CATGCAAGAC). The mip-specific TaqMan probe was 5′ –
AGCGCCACTCATAG labeled with a 6- carboxyfluorescein
(FAM) reporter dye at the 5′ end and a non-fluorescent
quencher at the 3′ end. The probe was conjugated to a minor
groove binder (MGB) to improve real-time PCR specificity
and sensitivity.
Results and discussion
The procedure to synthesize the nanoparticles was carefully
selected for its ability to produce particles at a large scale with
Nanoparticles for efficient magnetic isolation of L. pneumophila
good monodispersity.[32] Even though these characteristics
are not strictly necessary for magnetic separation experiments,
i t does improve the reproduc ib i l i ty o f su r face
functionalization and antibody coupling. The iron oxide nano-
particles (magnetite, Fe3O4) that were prepared are 8.6 nm
wide in diameter, with a narrow size distribution of 0.6 nm
(see transmission electron microscopy data, Fig. 1). The large
scale at which these nanoparticle are produced (>10 grams)
ensures that batch-to-batch differences during experiments
can be fully excluded.
Even though the functionalization of iron oxides is a well-
known research topic, multiple recent advances have been
reported [33]. We choose siloxane surface chemistry in this
regard, since it provides the particles with several important
properties. First of all, the ligand coating is covalently at-
tached to the surface, which improves its resistance to the
environment, merely extreme pH, heat or high ionic strength.
Secondly, the ligand can be designed with a specific applica-
tion in mind. In this case, a PEG backbone was preferred for
its excellent solubility in aqueous environments. Moreover,
the ligand was altered to have one functional carboxylic acid
end-group, which concentration on the nanoparticle can be
tailored by mixing with unaltered ligands.
As shown in Fig. 2, the ligand is prepared by a two-step
reaction involving an anhydride ring opening reaction and a
thiol-ene click chemistry reaction. The latter is very conve-
nient for siloxane chemistry since it occurs fast and without
notable side reactions. The product can be used without any
further purification, which reduces the chance of crosslinking
and hydrolysis of the siloxane group.
The presence of a carboxylic acid group on the ligand im-
plies that pH will have an influence on the charge of the
functionalized nanoparticle. To reduce this potential issue,
the modified ligand was mixed with unmodified ligands (si-
loxane-PEG10) during the nanoparticle functionalization
procedure. A fixed ratio of 10%modified to 90% unmodified
ligands was maintained throughout the experiments. Since the
subsequent coupling to antibodies will use the present func-
tional groups to form amide bonds, the influence of pHwill be
limited, which is necessary to ensure colloidal stability in
complex environments (such as buffer solutions).
After functionalization of the nanoparticles’ surface, Ab
were covalently coupled onto their carboxylic acid groups.
A well-known EDC-NHS approach was preferred for its re-
producibility and simplicity.[34] One major drawback of this
method is the non-directional bonding that occurs. Since a
protein contains multiple free amines, the orientation of the
protein can hardly be controlled. Hence a high percentage of
the antibodies will lose their activity because of a non-optimal
orientation (as shown in Fig. 3a).
The polyclonal antibodies used in this study are the whole
IgG fraction of leporine serum, derived from L. pneumophila
immunized rabbits. This IgG usually contains 1 to 5 % of target
specific antibodies. It is technically possible to purify this further
to a monospecific polyclonal fraction, but this is very time con-
suming. Moreover, the target species are bacteria, which make
the purification even more complex. It would require a column
coated with whole L. pneumophila bacteria, not just membrane
proteins, to ensure that no epitopes would be ignored. Therefore,
in this study, the full IgG fraction was used during the coupling
experiments, maximizing the range of targeted epitopes. We
argue that the gain of havingmonospecific polyclonal antibodies
is small if the bonding is non-directional anyway. A directional
(but much more complex) bonding strategy could definitely
profit from this on the other hand [34, 35].
The bioconjugated iron oxide nanoparticles were added to
monospecies spiked L. pneumophila solutions (1E7, 1E6, 1E5
and 1E4 cells mL−1) and incubated for 1 hour while rotation
the test tubes. No precipitation was observed, which is a
strong indication that the custom functionalized surface is
coping well with the complex environment and is keeping
the particle colloidally stable. The dispersion was loaded onto
a magnetic column (inside a circular magnet) and the super-
natant was collected. After a washing step, the column was
removed from the magnet and eluted to collect the
nanoparticle-bacteria complexes. This fraction was split to
perform all different characterization techniques.
Flow cytometry was selected as the main characterization
technique because of its ability to quantify fluorescently la-
beled bacteria with high accuracy. Since the L. pneumophila
strain was labeled with a gfp marker, detection and quantifi-
cation was straightforward. The results show that as expected
the type of antibody, coupled to the nanoparticle, has a pro-
found influence on the magnetic separation behavior. Table 1
shows the amount of bacteria found in the different fractions
that were magnetically separated from an initial solution of
5E6 bacteria per milliliter. The presence of antibodies
targeting the bacteria clearly has a positive influence on the
Fig. 1 The synthesized iron oxide (magnetite) nanoparticles are 8.6±
0.6 nm in size and are spherical
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separation capabilities of the nanoparticles. In the supernatant
of the negative control (pAb mur PAI-1), the concentration of
cells is more than 150 times higher. While the opposite can be
seen in the NP-cell fraction, where the negative control per-
forms more than 10 times worse. Moreover, the final fraction
is underestimated by the flow cytometer, since small clusters
of bacteria are formed after interaction with nanoparticles.
Hence multiple cells are shown as one event only. Experimen-
tal data revealed that the underestimation is approximately a
factor 2-3 (see Electronic SupplementaryMaterial, Figure S2).
The background of the flow cytometer, used in these experi-
ments, is approximately 3E3 cells mL−1; this number was not
subtracted from the experimental values, since this was a sys-
tematic error and the influence on the end results is minimal.
However, due to this substantial background signal, the limit
of detection is limited to 104 cells mL−1. Using other quanti-
fication techniques can drastically improve this limit of detec-
tion. An overview of different purification methods and their
respective recoveries can be found in the Electronic Supple-
mentary Material, Table S2. These results show that the nano-
particles are capable of selectively capturing target bacteria
from an aqueous solution, even though the antibodies are
coupled non-directionally and are not monospecific.
To further underline the capabilities of the functionalized
nanoparticles, a separation experiment was performed on a
mixed set of bacteria. This would give information about the
specificity of the nanoparticles and the behavior of the nega-
tive control. In an experiment with only one bacterial species
present, the negative control will always detect this bacterium,
albeit aspecifically, since no other targets are present. By care-
fully selecting the two different bacteria (L. pneumophila gfp-
labeled and E. coli rfp-labeled), we were able to discriminate
them in the flow cytometry plots and investigate the overall
performance. Figure 4 summarizes the data of these experi-
ments. The FCMplots of the supernatants are shown in the left
column, while the NP-cell fractions are shown in the right
column. The washing steps were omitted for clarity. In the
nanoparticle samples coated with pAb Leg (upper row), only
a minor presence of L. pneumophila in the supernatant is
shown, while a high concentration is present in the NP-cell
fraction. E. coli on the other hand stays in the supernatant and
is hardly present in the NP-cell fraction. We noticed a small
leak of green fluorescence into the red fluorescence detector,
which accounts for a significant portion of the visible dots in
the red ellipse. Keeping this background in mind, more than
90 percent of the bacteria were successfully separated.
Fig. 2 The allyl-PEG10 molecule is modified first by an anhydride ring opening on the hydroxyl group, resulting in a carboxylic acid group. Secondly
the allyl group is used in a thiol-ene click chemistry reaction to attach the siloxane
Fig. 3 Schematic overview of the
cell separation procedure. First,
the functionalized nanoparticles
were conjugated to the
corresponding antibodies via an
amide bond, induced by EDC-
NHS coupling chemistry (a).
Secondly, L. pneumophila
solutions were prepared (b),
which were brought into contact
with the nanoparticles and
magnetically separated (c).
Finally, the different collected
fractions were characterized by
flowcytometry and qPCR (d)
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Nevertheless, this clearly underlines the target-specific
magnetic separation that is occurring. In the negative
control samples (bottom row), both bacterial species
are mainly present in the supernatant, but only minimally in
the NP-cell fraction. We can therefore conclude that the neg-
ative control nanoparticles only interact aspecifically with the
bacteria, as expected.
The presented nanoparticle platform is capable of selective-
ly attracting bacterial species from a complex mixture. More-
over the ligand design is straightforward and thanks to the
usage of siloxanes, the ligand is covalently bound to the sur-
face of the NP. Even though the coupling of Ab is non-direc-
tional, this did not hamper the properties of the nanoparticles.
The selection of polyclonal Ab as targeting moieties broad-
ened the range of epitopes to which the NP could attach. The
magnetic separation strategy strongly reduces the presence of
surfactants or metal ions that are present in complex environ-
ments, which are known inhibitors for sensitive quantification
techniques like qPCR. We believe that this proof of concept
can be translated to a wide series of diagnostic applications as
a fast and efficient pre-concentration step. Future experiments
will optimize the antibody coupling and make use of mono-
specific Ab to further enhance the efficiency of the system.
Conclusions
Superparamagnetic iron oxide nanoparticles were functional-
ized with a heterobifunctional polyethylene glycol ligand and
subsequently bioconjugated with antibodies. The ligand has a
Fig. 4 The separation
capabilities of the nanoparticles
are still active in a mixed bacteria
environment. L. pneumophila
bacteria (gfp-labeled) were mixed
with E. coli bacteria (rfp-labeled)
at a 65/35 ratio (1.4E5/7.4E4
cells mL−1). The flow cytometry
measurements show that the rfp-
labeled E. coli bacteria remain in
the supernatant fraction of the
pAb Leg coated nanoparticles
(upper row), while the L.
pneumophila bacteria are present
in the NP-cell fraction. The
negative control nanoparticles
(pAb mur PAI-1, bottom row)
show a different behavior: both
species are visible in the
supernatant fraction, with only
minor presence in the NP-cell
fraction
Table 1 The type of antibody has a profound influence on themagnetic
separation behavior. This dataset was measured by flow cytometry, based
on 3 replicates
Collected cells mL−1 Supernatant Washing step NP-cell elution
NP-pAb Leg 1.1E4 (2.3%) 5.0E3 (1.1%) 4.4E5 (96.6%)
NP-pAb mur PAI-1 1.9E6 (82.7%) 3.5E5 (15.5%) 4.0E4 (1.1%)
Ratio 0.0057 0.014 11
A large amount of the bacteria is present in the supernatant of the negative
control (NP-pAb mur PAI-1), while the final fraction (NP-cell elution) in
comparison only contains a few percent. The opposite can be seen for the
bioconjugates that target L. pneumophila (NP-pAb Leg): a small number
of cells can be found in the supernatant, while a large number is present in
the final fraction. The ratio of the two types of conjugates is presented to
clarify the difference. The full data set (different concentrations of bacte-
ria: 1E4, 2E5, 2E6, 3E7 cells mL−1 ) can be found in the Electronic Sup-
plementary Material (Table S1)
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siloxane moiety on one end and one carboxylic group, intro-
duced by an anhydride ring opening, on the other end. We
used thiol-ene click chemistry for the siloxane modification,
since this type of reactions is fast and gives high yield without
side reactions. After surface functionalization of the nanopar-
ticles, antibodies were coupled to the surface. These biocon-
jugates were added to L. pneumophila bacteria and after mag-
netic separation, the different fractions were investigated by
flow cytometry and qPCR. An enrichment of bacteria was
visible in the eluted fraction of the column, showing that the
nanoparticles efficiently interact with the targeted species. The
negative control showed a more than 10-fold lower enrich-
ment, caused by aspecific adsorption. Moreover, the targeted
species were also attracted from a mixture of bacteria, where a
similar enrichment was obtained. These results indicate
that the surface functionalized bioconjugates can be used
for magnetic separation of bacteria from complex solutions,
with great efficiency, even though the antibodies are coupled
non-directionally.
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